Daily Stress and Vascular Function in Midlife as a Risk Factor for Cognitive Decline
Status:
COMPLETED
Trial end date:
2025-05-29
Target enrollment:
Participant gender:
Summary
The goal of this pilot clinical trial is to begin to understand how day-to-day stress affects cardiovascular health and brain function in middle-aged adults. The main question aims to answer is whether the link between daily stress and vascular dysfunction is a potential mechanism of increased risk for future cognitive decline. Participants will complete a 15-day testing cycle. During this cycle, participants will complete daily assessments of stress using an online survey tool for 14-consecutive days. On the last day of each cycle, vascular function will be assessed during a laboratory visit.
Phase:
NA
Details
Lead Sponsor:
University of Delaware
Collaborator:
National Institute of General Medical Sciences (NIGMS)